164 related articles for article (PubMed ID: 30673295)
1. Stereotactic body radiation therapy in cholangiocarcinoma: a systematic review.
Frakulli R; Buwenge M; Macchia G; Cammelli S; Deodato F; Cilla S; Cellini F; Mattiucci GC; Bisello S; Brandi G; Parisi S; Morganti AG
Br J Radiol; 2019 May; 92(1097):20180688. PubMed ID: 30673295
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review.
Lee J; Yoon WS; Koom WS; Rim CH
Strahlenther Onkol; 2019 Feb; 195(2):93-102. PubMed ID: 30206644
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Gkika E; Hallauer L; Kirste S; Adebahr S; Bartl N; Neeff HP; Fritsch R; Brass V; Nestle U; Grosu AL; Brunner TB
BMC Cancer; 2017 Nov; 17(1):781. PubMed ID: 29162055
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Brunner TB; Blanck O; Lewitzki V; Abbasi-Senger N; Momm F; Riesterer O; Duma MN; Wachter S; Baus W; Gerum S; Guckenberger M; Gkika E
Radiother Oncol; 2019 Mar; 132():42-47. PubMed ID: 30825968
[TBL] [Abstract][Full Text] [Related]
6. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience.
Polistina FA; Guglielmi R; Baiocchi C; Francescon P; Scalchi P; Febbraro A; Costantin G; Ambrosino G
Radiother Oncol; 2011 May; 99(2):120-3. PubMed ID: 21621289
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma.
Barney BM; Olivier KR; Miller RC; Haddock MG
Radiat Oncol; 2012 May; 7():67. PubMed ID: 22553982
[TBL] [Abstract][Full Text] [Related]
8. Actual over 3-year survival after stereotactic body radiation therapy in patients with unresectable intrahepatic cholangiocarcinoma.
Zhang XX; Ma HB; Li TH; Huang B; Jia NY; Meng Y
Clin Transl Oncol; 2023 Mar; 25(3):731-738. PubMed ID: 36401766
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiotherapy in intrahepatic cholangiocarcinoma: A systematic review.
Bisello S; Camilletti AC; Bertini F; Buwenge M; Arcelli A; Macchia G; Deodato F; Cilla S; Mattiucci G; Autorino R; Brandi G; Strigari L; Cammelli S; Morganti AG
Mol Clin Oncol; 2021 Aug; 15(2):152. PubMed ID: 34141431
[TBL] [Abstract][Full Text] [Related]
11. Single center experience using stereotactic body radiation therapy (SBRT) on orthotopic liver transplant protocol for unresectable cholangiocarcinoma.
Wu TC; Deng J; Chu FI; Sadeghi S; Finn R; Agopian VG; Lee P; Raldow AC
HPB (Oxford); 2024 Mar; 26(3):444-450. PubMed ID: 38142182
[TBL] [Abstract][Full Text] [Related]
12. Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis.
Autorino R; Bisiello S; Pappalardi B; Privitera V; Buwenge M; Piccolo F; Masciocchi C; Tagliaferri L; Macchia G; Curti CD; Luppatteli M; Cerrotta A; Morganti AG; Valentini V; Mattiucci G
Anticancer Res; 2020 Jun; 40(6):3417-3421. PubMed ID: 32487639
[TBL] [Abstract][Full Text] [Related]
13. Treatment Selection and Survival Outcomes With and Without Radiation for Unresectable, Localized Intrahepatic Cholangiocarcinoma.
Jackson MW; Amini A; Jones BL; Rusthoven CG; Schefter TE; Goodman KA
Cancer J; 2016; 22(4):237-42. PubMed ID: 27441741
[TBL] [Abstract][Full Text] [Related]
14. Repeated SBRT for in- and out-of-field recurrences in the liver.
Gkika E; Strouthos I; Kirste S; Adebahr S; Schultheiss M; Bettinger D; Fritsch R; Brass V; Maruschke L; Neeff HP; Lang SA; Nestle U; Grosu AL; Brunner TB
Strahlenther Onkol; 2019 Mar; 195(3):246-253. PubMed ID: 30353350
[TBL] [Abstract][Full Text] [Related]
15. Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study.
Cucchetti A; Cappelli A; Mosconi C; Zhong JH; Cescon M; Pinna AD; Golfieri R
Liver Int; 2017 Jul; 37(7):1056-1064. PubMed ID: 28177190
[TBL] [Abstract][Full Text] [Related]
16. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
Rim CH; Kim HJ; Seong J
Radiother Oncol; 2019 Feb; 131():135-144. PubMed ID: 30773180
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma.
Brunner TB; Eccles CL
Strahlenther Onkol; 2010 Dec; 186(12):672-80. PubMed ID: 21136029
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1).
Arcelli A; Buwenge M; Macchia G; Bertini F; Guido A; Deodato F; Cilla S; Scotti V; Rosetto ME; Djan I; Parisi S; Mattiucci GC; Cellini F; Fiore M; Bonomo P; Belgioia L; Niespolo RM; Gabriele P; Di Marco M; Simoni N; Mazzarotto R; Morganti AG;
Cancer Med; 2020 Nov; 9(21):7879-7887. PubMed ID: 32910549
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
[TBL] [Abstract][Full Text] [Related]
20. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
